Restless Legs Syndrome Market Sluggish Growth Rate Foreseen by 2023-2029
Restless legs syndrome market is projected to grow at a CAGR of 6.2% during the forecast period. The increase in the prevalence of restless legs syndrome (RLS) is a key factor responsible for the growth of the market. RLS is a disorder that is associated with the part of the nervous system that causes patients an urge to move the legs restlessly. According to the estimation of the National Institute of Neurological Disorders and Stroke (NIH), around 7-10 % of the US population has RLS. Moreover, the rising geriatric population further boosts the growth of the global market. As per the UN (United Nations), by 2050 around 1 in 6 (16%) citizens will be over the age of 65 years, globally, which was 1 in 11 (9%) in 2019. Old age, obesity, and snoring conditions lead to an increase in the rate of various types of sleep disorders which will create significant demand for diagnosis and treatment for obstructive sleep-wake disorders shortly.
However, the high cost of drugs and
therapy used for the treatment of restless leg syndrome coupled with low
healthcare budget in some developing countries may hinder the growth of the
market. For instance, the annual cost of Rotigotine (Neupro), a drug to treat
used to treat restless legs syndrome and periodic limb movement disorder can
cost up to $5,300 per year in the US. Huge R&D expenditure by market
players for the development of the novel intervention is anticipated to create
a considerable opportunity for market growth.
To Request
a Sample of our Report on Restless Legs Syndrome Market: https://www.omrglobal.com/request-sample/restless-legs-syndrome-market
Restless Leg Syndrome Market Segmentation
By Treatment
·
Medication
·
Therapy
·
Devices
By End-User
·
Hospitals
·
Homecare
A full Report of Restless Legs Syndrome Market is
Available @ https://www.omrglobal.com/industry-reports/restless-legs-syndrome-market
Regional Analysis
North America
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of
Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
Company Profiles
·
Akorn, Inc.
·
Arbor Pharmaceuticals, LLC
·
Boehringer Ingelheim GmbH
·
GlaxoSmithKline plc
·
Glenmark Pharmaceuticals Ltd.
·
Jazz Pharmaceuticals plc
·
Kyowa Hakko Kirin Co. Ltd.
·
LGM Pharma
·
Mallinckrodt Pharmaceuticals
·
Merck Co, Inc.
·
Mylan N.V.
·
Pfizer, Inc.
·
Serina Therapeutics, Inc.
·
Teva Pharmaceutical Industries, Ltd.
·
UCB S.A.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment